Diana M. Brainard M.D.
Net Worth

Last updated:

What is Diana M. Brainard M.D. net worth?

The estimated net worth of Dr. Diana M. Brainard M.D. is at least $9,313,520 as of 19 Nov 2024. He owns shares worth $8,537,130 as insider, has earned $676,390 from insider trading and has received compensation worth at least $100,000 in AlloVir, Inc..

What is the salary of Diana M. Brainard M.D.?

Dr. Diana M. Brainard M.D. salary is $20,000 per year as Chief Executive Officer & Director in AlloVir, Inc..

How old is Diana M. Brainard M.D.?

Dr. Diana M. Brainard M.D. is 54 years old, born in 1971.

What stocks does Diana M. Brainard M.D. currently own?

As insider, Dr. Diana M. Brainard M.D. owns shares in one company:

Company Title Shares Price per share Total value
AlloVir, Inc. (ALVR) Chief Executive Officer & Director 723,363 $11.8 $8,537,130

What does AlloVir, Inc. do?

Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts.

ALVR logo
ALVR
AlloVir, Inc.
$11.8

Diana M. Brainard M.D. insider trading

AlloVir, Inc.

Dr. Diana M. Brainard M.D. has made 34 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he sold 8,706 units of ALVR stock worth $4,780 on 19 Nov 2024.

The largest trade he's ever made was exercising 41,421 units of ALVR stock on 5 Feb 2024. As of 19 Nov 2024 he still owns at least 723,363 units of ALVR stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 8,706 $0.55 $4,780
Sale
Common Stock 10,609 $0.87 $9,177
Sale
Common Stock 9,752 $0.78 $7,597
Sale
Common Stock 1,493 $0.82 $1,217
Sale
Common Stock 5,390 $0.74 $3,994
Sale
Common Stock 3,091 $0.76 $2,349
Sale
Common Stock 10,847 $0.74 $7,973
Sale
Common Stock 9,731 $0.75 $7,298
Sale
Common Stock 1,489 $0.72 $1,072
Sale
Common Stock 5,149 $0.79 $4,078
Sale
Common Stock 3,075 $0.75 $2,303
Sale
Common Stock 10,240 $0.8 $8,151
Sale
Common Stock 9,601 $0.75 $7,210
Sale
Common Stock 1,533 $0.77 $1,183
Sale
Common Stock 5,155 $0.71 $3,650
Sale
Common Stock 3,097 $0.7 $2,152
Sale
Common Stock 41,421 $0.67 $27,752
Sale
Common Stock 9,500 $0.67 $6,365
Sale
Common Stock 1,664 $0.64 $1,063
Sale
Common Stock 4,382 $1.69 $7,410
Sale
Common Stock 2,689 $1.63 $4,386
Sale
Common Stock 8,581 $1.58 $13,558
Sale
Common Stock 1,325 $1.98 $2,618
Sale
Common Stock 4,055 $2.79 $11,313
Sale
Common Stock 11,361 $2.5 $28,357
Sale
Common Stock 8,342 $3.56 $29,714
Sale
Common Stock 5,275 $3.05 $16,062
Sale
Common Stock 4,536 $4.21 $19,115
Sale
Common Stock 8,408 $3.71 $31,185
Sale
Common Stock 5,122 $6.63 $33,933
Sale
Common Stock 34,435 $5.08 $174,861
Sale
Common Stock 4,515 $7.27 $32,811
Sale
Common Stock 4,564 $7.76 $35,430
Sale
Common Stock 29,135 $4.33 $126,271
Purchase
Common Stock 6,300 $17 $107,100

AlloVir key executives

AlloVir, Inc. executives and other stock owners filed with the SEC: